Published in Mol Carcinog on August 31, 2015
Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the cold. Cell Mol Life Sci (2016) 0.79
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype. Oncotarget (2016) 0.78
MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer. Oncotarget (2017) 0.75
RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection. Oncotarget (2017) 0.75
The exon junction complex regulates the splicing of cell polarity gene dlg1 to control Wingless signaling in development. Elife (2016) 0.75
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients. J Mol Neurosci (2017) 0.75
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature (2008) 11.66
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
Targeting multidrug resistance in cancer. Nat Rev Drug Discov (2006) 10.55
Wnt signalling and its impact on development and cancer. Nat Rev Cancer (2008) 8.37
A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84
G-protein-coupled receptors and cancer. Nat Rev Cancer (2007) 6.80
Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol (2007) 4.75
GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol (2003) 4.60
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol (1999) 4.04
Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol (2007) 3.11
Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J (1993) 2.98
Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res (2005) 2.62
O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol (2010) 2.45
Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet (2012) 2.33
Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem (1998) 2.22
The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer (2010) 2.20
Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem (2003) 2.00
Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem (2006) 1.86
Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol (1997) 1.73
Gastrointestinal stem cells in development and cancer. J Pathol (2009) 1.73
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci (2004) 1.62
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med (2010) 1.51
Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res (2008) 1.50
LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene (2011) 1.43
Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress. Biochem Biophys Res Commun (1997) 1.43
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene (2008) 1.37
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol (2009) 1.34
Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem (1996) 1.29
Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res (2010) 1.20
RBM3, a novel human gene in Xp11.23 with a putative RNA-binding domain. Hum Mol Genet (1995) 1.18
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. J Transl Med (2011) 1.15
The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death. Pediatr Res (2010) 1.14
Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum Mol Genet (2002) 1.12
Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity. J Cell Biochem (2009) 1.12
The RNA-binding protein RBM3 is involved in hypothermia induced neuroprotection. Neurobiol Dis (2011) 1.11
ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate. Cell Cycle (2009) 1.01
Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells (2014) 0.99
Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines. Int J Mol Med (2012) 0.98
One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci (2013) 0.97
Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells. Lab Invest (2013) 0.94
Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing. Cancer Res (2013) 0.93
Enhanced survival of skeletal muscle myoblasts in response to overexpression of cold shock protein RBM3. Am J Physiol Cell Physiol (2011) 0.85
Cancer-associated mesenchymal stem cells aggravate tumor progression. Front Cell Dev Biol (2015) 0.82
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions. Eur J Cancer (2013) 0.81
Differential expression of the RNA-binding motif protein 3 in human astrocytoma. Chin Med J (Engl) (2013) 0.79
Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells. Chin J Cancer Res (2012) 0.78